Showing 101 - 120 results of 2,268 for search '"drug safety"', query time: 0.71s Refine Results
  1. 101
  2. 102

    Advancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports by Theodoros G. Soldatos, Sarah Kim, Stephan Schmidt, Lawrence J. Lesko, David B. Jackson

    Published 2022-05-01
    “…Several methods have been developed to analyze such data, aiming to improve pharmacovigilance and drug safety. In this work, we provide a brief review of key directions to quantitatively analyzing adverse events and explore the potential of augmenting these methods using additional molecular data descriptors. …”
    Get full text
    Article
  3. 103
  4. 104
  5. 105
  6. 106
  7. 107
  8. 108
  9. 109

    Using Twitter Data for Cohort Studies of Drug Safety in Pregnancy: Proof-of-concept With β-Blockers by Ari Z Klein, Karen O'Connor, Lisa D Levine, Graciela Gonzalez-Hernandez

    Published 2022-06-01
    “…ConclusionsOur ability to detect pregnancy outcomes for Twitter users who posted tweets reporting that they took or may have taken a β-blocker during pregnancy suggests that Twitter can be a complementary resource for cohort studies of drug safety in pregnancy.…”
    Get full text
    Article
  10. 110

    An EGFP Knock-in Zebrafish Experimental Model Used in Evaluation of the Amantadine Drug Safety During Early Cardiogenesis by Shi Ouyang, Shi Ouyang, Wu-Ming Qin, Wu-Ming Qin, Yu-Juan Niu, Yu-Juan Niu, Yong-He Ding, Yong-He Ding, Yun Deng, Yun Deng

    Published 2022-04-01
    “…Amantadine drug treatment-induced ectopic expression of vmhc gene in the atrium and caused cardiac-looping or LR asymmetry defects to dose-dependently during early cardiogenesis, concomitant with dramatically reduced expression levels of key genes required for myocardium differentiation and LR asymmetry.ConclusionWe generated a novel zebrafish KI animal model in which EGFP reports the ventricle chamber-specific expression of vmhc gene dynamics that is useful to effectively assess drug safety on the cardiac morphology in vivo. Specifically, this study identified teratogenic effects of amantadine drug during early cardiogenesis dose dependent, which could be likely conveyed by inhibiting expression of key genes required for cardiac myocardium differentiation and LR asymmetry.…”
    Get full text
    Article
  11. 111

    A common data model for harmonization in the Nordic Pregnancy Drug Safety Studies (NorPreSS) by Jacqueline M. Cohen, Carolyn E. Cesta, Lars Kjerpeseth, Maarit K. Leinonen, Óskar Hálfdánarson, Øystein Karlstad, Pär Karlsson, Morten Andersen, Kari Furu, Vidar Hjellvik

    Published 2021-08-01
    “…We describe a CDM developed for the Nordic Pregnancy Drug Safety Studies (NorPreSS), including details on data sources and structure of the data tables. …”
    Get full text
    Article
  12. 112
  13. 113
  14. 114

    Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database by Isaac V. Cohen, Tigran Makunts, Ruben Abagyan, Kelan Thomas

    Published 2021-03-01
    “…The goal of this study was to evaluate the risks due to MDMA ingestion alone or in combination with other common medications and drugs of abuse using the FDA drug safety surveillance data. To date, nearly one thousand reports of MDMA use have been reported to the FDA. …”
    Get full text
    Article
  15. 115
  16. 116

    Use of Medicines in Children: Pharmacological and Practical Issues by Shashikant Bhargava, Prashant Mishra, Shiwangi Rana

    Published 2023-07-01
    Subjects: “…Pediatric; Pharmacokinetics; Drug Safety…”
    Get full text
    Article
  17. 117
  18. 118
  19. 119

    A tree-based scan statistic for zero-inflated count data in post-market drug safety surveillance by Goeun Park, Inkyung Jung

    Published 2022-09-01
    “…The two methods were illustrated using Korea Adverse Event Reporting System data from the Korea Institute of Drug Safety and Risk Management.…”
    Get full text
    Article
  20. 120